Info

Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type 2 cryoglobulinemia. N Engl J Med 1992;327:1490-1495. 35.

Cacoub P, Fabiani FL, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-132.

Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjogren's syndrome associated 36. with chronic hepatitis C virus liver disease. Lancet 1992;339:321-323.

Mariette X, Zerbib M, Jaccard A, Schenmetzler C, 37.

Danon F, Clauvel JP. Hepatitis C virus and Sjogren's syndrome. Arthritis rheum 1993;36:280-281. Siegel LB, Cohn L, Nashel D. Rheumatic manifestations of hepatitis C infection. Sem Arthritis Rheum 38. 1993;23:149-154.

Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: A mimic of rheumatoid arthritis. J Rheumatol 39. 1996;23:979-983.

Ferri C, Monti M, La Civita L, et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 1994;24:781-784. 40.

Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:3047-3053.

Sikuler E, Schnaider A, Zilberman D, Hilzenrat N, 41. Shemer-Avni Y, Neumann L, Buskila D. Hepatitis C virus infection and extrahepatic malignancies. J Clin Gastroenterol 1997;24:87-89.

Wilson RA. Extrahepatic manifestations of chronic 42.

viral hepatitis. Am J Gastroenterol 1997;92:4-17. Strassburg CP, Manns MP. Autoimmune hepatitis versus viral hepatitis C. Liver 1995;15:225-232. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. hepa- 43. tology 1992;15:567-571.

Alberti A, Morsica G, Chemello L, et al. Hepatitis C viremia and liver disease in symptom free individuals with anti-HCV. Lancet 1992;340:677-698. 44. Alter HJ. To C or not to C: These are the questions. Blood 1995;85:1681-1695. Koziel MJ. Immunology of viral hepatitis. Am J Med 1996;100:98-109.

Sansonno D, Cornacchiulo V, Iacobelli AR, Di Ste- 45. fano R, Lospalluti M, Dammacco F. Localiztion of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995;21:305-312.

Sinico RA, Winearls CG, Sabadini E, Fornasieri A, Catiglione A, D'Amico. Identification of glomerular immune deposits in cryoglobulinemic glomerulonephritis. Kidney Int 1988;34:109-116. Szymanski IO, Pullman JM, Underwood JM. Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemia type II. Am J Clin Pathol 1994;102:278-283.

Rice CM, Walker CM. Hepatitis C virus-specific T lymphocyte responses. Curr Opinion Immunol 1995;7:532-538.

Koziel MJ, Dudley D, Afdhal N, et al. Hepatitis C virus (HCV) specific cytotoxic T lymphocytes recognize epitopes in the core and envelop proteins of HCV. J Virol 1993;67:7522-7532. Cerny A, McHutchison JG, Pasquinelli C, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995;95:521-530. Chu CM, Liaw YF. Coexpression of intercellular adhesion molecule-I and class I major histocompat-ibilty complex antigens on hepatocyte membrane in chronic viral hepatitis. J Clin Pathol 1993;46:1004-1008.

Mosnier JF, Scoazec JY, Marcellin, Degott C, Ben-hamou JP, Feldmann G. Expression of cytokine-dependent immune adhesion molecules by hepato-cytes and bile duct cells in chronic hepatitis C. Gastroenterology 1994; 107:1457-1468. Liaw YF, Lee CS, Tsai SL, et al. T-cell mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995;22:1368-1373.

Garyfallos A, Raptopoulou-Gigi M, Orphanou H, Spaia S, Petridou P, Vayionas G. Interleukin 2-dependent immunoregulatory function in hemodialysis patients with chronic hepatitis C. J Investig Allergol Clin Immunol 1995;5:255-258. Fukuda R, Satoh S, Nguyen XT, et al. Expression rate of cytokine mRNA in the liver of chronic hepatitis C: Comparison with hepatitis B. J Gastroenterol 1995;30:41-47.

Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM.l. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and posttreat-ment with interferon alpha. Hepatology 1996;24:6-9.

Jirillo E, Greco B, Caradonna L, et al. Evaluation of cellular immune responses and soluble mediators in patients with chronic hepatitis C virus infection. Im-munopharmacol Immunotoxicol 1995;17:347-364.

Czaja AJ. Autoimmune hepatitis, evolving concepts and treatment strategies. Dig Dis Sei 1995;40:435-456.

Pawlotsky JM, Roudot-Thoraval F, Simmonds P, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122:169- 173. Richardet JP, Lons T, Johanet C, et al. Prevalence and characteristics of anti-tissue antibodies in chronic hepatitis caused by hepatitis C virus (French). Gastroenterol Clin Biol 1994;18:819-823. Prieto J, Yuste JR, Beloqui O, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the an. Hepatology 1996;23:199-204.

Tran A, Quaranta JF, Benzaken S, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993;18:253-257. Buskila D, Schnaider A, Neumann L, et al. Musku-loskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998;28:1-8. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.

Hartmann H, Schott P, Polzien F, et al. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenterol, 1955;33:643-50. Karlsberg PL, Lee WM, Casey DL. Coc CJ, Cruz PD Jr. Cutavasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus induced mixed cryoglobulinemia. Arch Dermatol 1995; 131:11191123.

Dupin N, Chosidow O, Lunel F, et al. Essential mixed cryoglobulinemia: a comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch Dermatol 1995;131:1124-1127.

Daoud MS, Gibson LE, Daoud S, el-Azhary RA. Chronic hepatitis C and skin diseases: a review. Mayo Clinic Proc 1995;70:559-564. Johnson RJ, Willson R, Yamabe H. et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994;46:1255-1263.

Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis C virus-associated glomerulonephritis. Effect of a interferon. Kidney Int 1994;46:1700-1704. Khella SL, Frost S, Hermann GA, et al. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alpha: case report and literature review. Neurology 1995;45:407^111.

60. Stehaman-Breen C, Willson R, Alpers CE, Gretch D, Johnson RJ. Hepatitis C associated glomerulonephritis. Curr Opin Nephrol Hypertens 1995;4:287-294.

61. Weiner SM, Berg T, Berthold H et al. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol 1998;29:375-384.

62. Uneo Y, Kinoshita R, Kishimoto I, Okamoto M. Polyarthritis associated with hepatitis C virus infection. Br J Rheumatol 1994;33:289-291.

63. Uneo Y, Kinoshita R, Tsujinoue H, Kato M. A case of hepatitis C virus (HCV)-associated arthritis. Quantitative analysis of HCV RNA of the synovial fluid and the serum. Br J Rheumatol 1995;34:691-692. ■

64. Ueno Y, Kondo K, Kidokoro N, Kobashi R, Kanaji K, Matsumura T. Hepatitis C infection and polymyositis. Lancet 1995;346:319-320.

65. Bon E, Cantagrel A, Moulinier L, et al. Rheumatic manifestations of chronic hepatitis C and response to the treatment with interferon alpha 2b (French). Rev Rheum Ed Fr 1994;61:497-504.

66. Kimura Y Kajiyama K Nomura H. Severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C associated with systemic lupus erythematosus (Japanese). Fukuoka Igaku Zasshi-Fukuoka Acta Medica 1004;85:329-323.

67. Marchesoni A, Buttafarano N, Podico M. Tosi S. Hepatitis C virus antibodies and systemic lupus erythematosus. Clin Exp Rheumatol 1995; 13:267268.

68. Abu-Shakra M, El-Sana S, Margalith M, Sikuler E, Neumann L, Buskila D. Hepatitis B and C viruses serology in patients with SLE. Lupus 1997;6:543-544.

69. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW. Polymyosistis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995;38:437^139.

70. Nishikai M, Miyairi M, Kosaka S. Dermatomyositis following infection with hepatitis C virus. J Rheumatol 1994;21:1584-1585.

71. Horsmans Y, Geubel AP. Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet 1995;345:1236.

72. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.

73. Pawlotsky JM, Ben Yahia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841-848.

74. Wattiaux MJ, Jouan-Flahault C, Youinou P, et al. Association of Gougerot-Sjögren syndrome and viral hepatitis C: apropos of 6 cases (French). Annal Med Intern 1995;146:247-250.

Marrone A, DiBisceglie AM, Fox P. Absence of hepatitis C viral infection among patients with primary Sjogren's syndrome. J Hepatol 1995;22:599. King PD, McMurray RW, Becherer PR. Sjogren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J gastroenterol 1994;89:1047-1050. Quint L, Deny P, Guillevin L, et al. Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients. Clin Exp Rheumatol 1991;9:253-257. Cacoub P, Lunel-Fabiani F, Du LT. Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992;116:605-606.

Hearth-Holmes M, Zahradka SL, Baethga BA, Wolf RE. Leukocytoclastic vasculitis associated with hepatitis C. Am J Med 1991;90:765-766. Durand JM, Kaplanski G, Richard MA, et al. Cutaneous vasculitis in a patient infected with hepatitis C virus. Detection of hepatitis C virus RNA in the skin by polymerase chain reaction. Br J Dermatol 1993;128:359-360.

Marcellin P, Pouteau M, Benhamou JP. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 1995;22:364-369. Roithinger FX, Allinger S, Kirchgatterer A, et al. A lethal course of chronic hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to interferon treatment. Am J Gastroenterol 1995;90:1006-1008.

Gorg S, Niederstadt C, Klouche M, et al. Intestinal vasculitis and glomerulonephritis in hepatitis C-associated cryoglobulinemia. Immunitat und Infektion 1995;23:29-31.

Moder KG, Lindor K. Muskuloskeletal symptoms associated with hepatitis C. Arthritis Rheum 1995;38(suppl):284 (abstr).

Romero Portales M, De Diego Lorenzo A, Rivera J, et al Rheumatologie and autoimmune manifestations in patients with chronic hepatitis C virus infection. Rev Esp Enferm Dig 1997;89:591-598. Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C virus infection: Another infectious disease relationship. Arch Intra Med 1997;157:2497-2500. Tran A, Quaranta JF, Beusnel C, et al: Hepatitis C virus and Hashimoto thyroiditis. Eur J Med 1992;1:116-118.

Kawaguchi K, Okuwaki J, Takami S. A case of HCV-RNA positive liver cirrhosis with hypergammaglobulinemia and high titers of ANA, accompanied by hypothyroidism (Japanese). Jpn J Gastroenterol 1995;92:909-913.

89. Abuaf N, Lunel F, Giral P, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993;18:359-364.

90. Quaranta JF, Tran A, Regnier D, et al. High prevalence of antibodies to hepatitis C virus in patients with anti-thyroid autoantibodis. J Hepatol 1993;18:136-138.

91. Tran A, Benzaken S, Braun HB, et al. Anti-GOR and anti thyroid autoantibodies in patients with chronic hepatitis C. Clin Immunol Immunopathol 1995;77:127-130.

92. Paggi A, Leri O, Taliani G, et al. Hepatitis C virus and autoimmune thyroid diseases, Possible non co-incidential association. Eur J Int Med 1995;6:33-36.

93. Preziati D, LaRosa L, Covini G, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon-alpha 2a. Eur J Endocrinol 1995;132:587-593.

94. Nagayama Y, Ohta K, Tsuruta M, et al: Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatistis:our studies and review of the literature. Endocrinol J 1994;41:565-572.

95. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G. Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991 ;59:319— 320.

96. Yamabe H, Johnson RJ, Gretch DR. et al. Hepatitis C rirus infection membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995;6:220-223.

97. Johnson RJ, GDR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-470.

98. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997;25:1237— 1244.

99. Lacaille F, Zylberberg H, Hagege H, Roualdes B, Meyrignac C, Chousterman M, Girot R. Hepatitis C associated with Guillain-Barre syndrome. Liver 1998;18:49-51.

100. Colombo M. Hepatocellular carcinoma. J Hepatol 1992;15:225-236.

101. Ferri C, Caracciolo F, Zignego Al et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-394.

102. Isselbacher KJ, Dienstag JL. Tumors of the liver and biliary tract. In: Fauci AS, Braunwald E, Isselbacher KJ et al, eds., Harrison's principles of

Internal Medicine. New York: McGraw-Hill 14th edn 1998:579.

103. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C. A prospective study of 251 patients. Hepatology 1995;21:650-655.

104. Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Rpupon R and Rpupon R. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435-1440.

105. Fattovich G, giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463^172.

106. Ferri C, Caracciolo F, Zignego AL et al. Hepatitis C virus infection in patients with non Hodgkin's lymphoma. Brit J Clin Invest. 1995;25:833-837.

107. Izumi T, Sasaki R, Tsunoda S, Akutsu M, Okamoto H, Minura Y B cell Malignancy and hepatitis C virus infection. Leukemia 1997;(suppl 3):516—518.

108. Silvestri F, Barillari G, Fanin R, et al. The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma. Leukemia 1997;11:2157-2161.

109. Naschitz JE, Zuckerman E, Elias N, Yeshurun D. Primary hepatosplenic lymphoma of the B-cell variety in a patient with hepatitis C liver cirrhosis. Am J Gastroenterol 1994;89:1915-1916.

110. Ellenrieder V, Beckh K, Muller D, Klatt S, Adler G. Intrahepatic high-grade malignant non-Hodgkin lymphoma in a patient with chronic hepatitis C infection. Z Gastroenterol 1996;34:283-285.

111. Satoh T, Yamada T, Nakano S, et al. The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis c virus. Cancer 1997;80:1981-1988.

112. Gil J, Rodríguez C, del Toro J, Montenegro T, Fernández-Cruz E, Menárguez J. Fulminant hepatosplenic B cell lymphoma in a young patient with HCV-chronic hepatitis. Leukemia 1998; 12:10051006

113. Perl A, Gorevic PD, Ryan DH, Condemi JJ, Ruszkowski RJ, Abraham GN. Clonal B cell expansion in patients with essential mixed cryoglobulinemia. Clin Exp Immunol 1989;76:54-60.

114. Monteverde A, Rivano MT, Allegra GC, et al. Essential mixed cryoglobulinemia type II: A manifestation of 12 cases with special reference to immuno-histochemical findings. Acta Haemtol 1988;79:20-25.

115. Invernizzi F, Pioltelli P, Cattaneo R, Gavazzeni V, Borzini P, Monti G, Zanussi C. A long-term follow-

up study in essential mixed cryoglobulinemia. Acta Haematol 1979;61:93-99.

116. Mussini C, Ghini M, Zanni G, Campioli D, Bianconi G, Artusi T. Cryoglobulinemia: Bone marrow histological investigation. Con Tissue Res 1992; 11:25.

117. Mussini C, Mascia MT, Zanni G, Curci G. A cy-tomorphological and immunohistochemical study of bone marrow in the diagnosis of essential mixed type II cryoglobulinemia. Haematologica 1991 ;76:389— 391.

118. De Vita S, Sanaonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86:1887-1892.

119. Franzin F, Efremov DG, Pozzato G et al. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Hematol 1995;90:548-552.

120. De Vita S, Sacco C Sanaonno D, et al. Characterization of overt B-cell lymphomas in patients with Hepatitis C virus infection. Blood 1997;90:776-782.

121. Ascoli V, Coco FL Artini M, Levrero M, Martelli M, Negro F. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 1998;109:600-609.

122. Lai R, Weiss LM. Hepatitis C virus and Non-Hodgkin's lynphoma. Am J Clin Pathol 1998;109:508-510.

123. La Civita L, Zignego AL, Monti M, Longombardo G, Greco F, Pasero G, Ferri C. Type C hepatitis and chronic lymphocytic leukemia (letter). Eur J cancer 1996;32A: 1819-1820.

124. Marinella MA, Moseley RH. Chronic lymphocytic leukemia complicating chronic hepatitis C infection. J Clin Gastroenterol 1996;23:302.

125. Porter SR, Lodi G, Chandler K, Kumar N. De-velopmant of squamous cell carcinoma in hepatitis C virus-associated lichen planus. Oral Oncol 1997;33:58-59.

126. Carrozzo M, Carbone M, Gandolfo S, Valente G, Colombatto P, Ghisetti V. An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol 1997;33:220-225.

127. El-Refaie A, Savage K, Bhattacharya S et al. HCV-associated hepatocellular carcinoma without cirrhosis. J hepatol 1996;24:277-285.

128. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chrinic hepatitis C. Hepatology 1998;27:1394-1402.

129. De-Mitri MS, Poussin K, Baccarini P Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beau-grand M, Pisi E, Christian Brechot, Paterlini P. HCV

associated liver cancer without cirrhosis. Lancet 1995;345:413-415.

130. Morris JD, Eddleston AL, Crook T. Viral infection and Cancer. Lancet 1995;346:754-758.

131. Gorevic PD, Frangione B. Mixed cryoglobulinemia cross- reactive idiotypes: implication for relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991;28:79-94.

132. Ferri C, Monti M, La Civita L et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinemia. Euro. J. Clin. Inves. 1994;24:781-784.

133. Mishiro S, Takeda K, Hoshi Y, Yoshikawa A, Gotanda T, Itoh Y. An auto-antibody cross-reactive to hepatitis C-virus core and a host nuclear antigen. Autoimmunity 1991;10:269-273.

134. Ellis M, Rathaus M, Amiel A, Manor Y, Klein A, Lishner M. Monoclonal lymphocytic proliferation and bcl-2 rearrangement in essential mixed cryoglobulinemia. Europ. J. Clin. Invest 1995;25:833-837.

135. Lau JYN, Xie X, Lai MMC, WU PC. Apopto-sis and viral hepatitis. Seminars in liver disease 1998;18:169-176.

136. Zignego AL, Giannelli F, Giannini C et al. Bcl-2 rearrangement in mixed cryoglobulinemia and HCV-related chronic disease. Abstracts of the International Meeting of hepatitis C virus and related viruses. Molecular virology and pathogenesis, Venezia, June 1998:169.

137. Ishido S, Fujita T, Hotta H. Complex formation of hepatitis C virus NS3 protein with the P53 tumor suppressor protein. Abstracts of the International Meeting of hepatitis C virus and related viruses. Molecular virology and pathogenesis, Venezia 1998:090

138. Chen SY, Kao CF, Chen JY, Lee YHWL. Direct association of the hepatitis C virus core protein with tumor suppressor P53 modulates the transcriptional activity of P53. Abstracts of the International Meeting of hepatitis C virus and related viruses. Molecular virology and pathogenesis, Venezia 1998:104.

© 2000 Elsevier Science B.V. All rights reserved. Cancer and Autoimmunity Y. Shoenfeld and M. E. Gershwin, editors

Natural Arthritis Relief

Natural Arthritis Relief

Natural Arthritis Relief details a unique method of reversing Rheumatoid Arthritis Symptoms by removing numerous arthritis triggers as well as toxins using a simple 5 step natural process.

Get My Free Ebook


Post a comment